Immune Management ApS: Financial statements 2021
CVR: 38726137
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Immune Management ApS (CVR 38726137) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -26,044 and a net result of DKK -27,743 compared with DKK -116,564 the year before. Equity in the 2021 report amounted to DKK 145,357. The solvency ratio was 91%.
- Gross Profit
- DKK -26,044
- Profit/Loss
- DKK -27,743
- Equity
- DKK 145,357
- Total Assets
- DKK 159,729
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -26K | -28K | 145K | 0 |
| 2020 | - | -17K | -117K | 230K | 0 |
| 2019 | - | 621K | 99K | 401K | - |
| 2018 | - | 500K | -55K | 303K | 1 |
| 2017 | - | 818K | 111K | 358K | 1 |
Official annual report
Find more companies like Immune Management ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Immune Management ApS has published its annual report for 2020. Gross profit came to DKK -16,722, and the net result was DKK -116,564.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.